tykhr
sign in
free sign up
4D Molecular Therapeutics Inc
Biotechnology
Healthcare
FDMT
55.74 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
7.51
52 week high
16.82
high
8.01
52 week low
0.00
low
7.50
growth
-36.05 %
previous Close
7.40
P/E ratio
market cap
280 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
342657.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top